Analysis of the lymphocyte count in type 2 diabetic patients with coronavirus disease (COVID-19): A retrospective study in a centralized treatment center
Authors:
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 166, 108340
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- T Lymphocyte Subsets Associated With Prevalent Diabetes in Veterans With and Without Human Immunodeficiency VirusThe Journal of Infectious Diseases, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?The Lancet Respiratory Medicine, 2020
- Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS CoronavirusJournal of Virology, 2020
- [A pathological report of three COVID-19 cases by minimally invasive autopsies].2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- MHC Molecules, T cell Receptors, Natural Killer Cell Receptors, and Viral Immunoevasins—Key Elements of Adaptive and Innate Immunity2019
- The impact of macroautophagy on CD8+ T‐cell‐mediated antiviral immunityImmunological Reviews, 2013
- Differential Virological and Immunological Outcome of Severe Acute Respiratory Syndrome Coronavirus Infection in Susceptible and Resistant Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2Journal of Virology, 2009
- Peripheral Lymphocyte Subset of Patients with Pancreatic Diabetes MellitusKansenshogaku Zasshi, 1996